Biotechnology Focus Podcast

075 | Partnerships, potential cures and pandemics      Welcome to another episode of Biotechnology Focus radio. This week has brought new partnerships and novel research to light from across Canada.   An international partnership sets its sight on developing a cure for Alzheimer’s disease  A recent study on Huntington’s could aid cognitive decline  Research suggests link between mortality rates of influenza pandemics   And implanting a potential cure for type 1 diabetes   Welcome to another episode of Biotechnology Focus radio. I am your host, Michelle Currie, here to give you a run-down of the top stories of Canada’s biotech scene.    +++++    A deal has been signed between the Krembil Research Institute and French multinational pharmaceutical company, Servier, for the development of a potential disease-modifying drug for Alzheimer’s disease.  This strategic research partnership agreement with Toronto-based company Treventis Corp., a company founded by the director of Krembil,